1) chronic hepatitis B
慢性乙型肝炎
1.
The relationship between HBV viral loads and liver damage severity in patients with HBeAg-negative chronic hepatitis B;
HBeAg阴性慢性乙型肝炎病毒载量与肝损害的关系
2.
Recent advance of telbivudine for the treatment of chronic hepatitis B;
替比夫定治疗慢性乙型肝炎的新进展
3.
Study on efficacy of Adefovirdipivoxil therapy for patients with chronic hepatitis B resistant to Lamivudine;
阿德福韦酯用于拉米夫定耐药慢性乙型肝炎的疗效研究
2) hepatitis B
慢性乙型肝炎
1.
Clinical evaluation of combination therapy of lamivudine and interferon α against chronic hepatitis B;
干扰素α联合拉米夫定治疗慢性乙型肝炎的疗效观察
2.
Therapeutic Effect of Stronger Neo-minophagen C on Chronic Hepatitis B;
复方甘草甜素注射液治疗慢性乙型肝炎疗效观察
3.
Detection and significance of interlerkin 8 and interleukin 10 levels and HBVDNA in serums from patients with chronic hepatitis B;
慢性乙型肝炎患者血清HBVDNA含量与IL-8、IL-10水平检测及临床意义
3) Chronic hepatitis
慢性乙型肝炎
1.
Multicenter clinical study about the action of Fuz heng Huayu Capsule against liver fibrosis with chronic hepatitis B;
扶正化瘀胶囊干预慢性乙型肝炎肝纤维化作用的多中心临床研究
2.
The expression of P16 in hepatocellular carcinoma and chronic hepatitis;
P16蛋白在原发性肝细胞肝癌及慢性乙型肝炎中表达情况探讨
3.
Clinical research for treatment of chronic hepatitis with magnesium isoglycyrrhizinate;
异甘草酸镁治疗慢性乙型肝炎的临床观察
4) chronic type B hepatitis
慢性乙型肝炎
1.
Study of Lamivudine combined with Fuzheng-Fugan decoction on chronic type B hepatitis and effect on drug fast;
拉米夫定联合扶正复肝方治疗慢性乙型肝炎及对拉米夫定耐药的影响研究
2.
Curative Effect on Shrinking Spleen of Heluo Shugan Jiaonang ( Heluo Shugan Capsule) for Treatment of Chronic Type B Hepatitis;
和络舒肝胶囊治疗慢性乙型肝炎缩脾疗效观察
3.
Study of Adefovir on chronic type B hepatitis with Lamivudine resistance;
阿德福韦治疗拉米夫定耐药慢性乙型肝炎的研究
5) Chronic B hepatitis
慢性乙型肝炎
1.
Observation of curative effects of oxymatrine combines with vaccae in the treatment of chronic B hepatitis;
苦参素联合微卡治疗慢性乙型肝炎32例
2.
To Evaluate the Regulation of Classical Differential Diagnosis of Traditional Chinese Medicine in Patients with Chronic B Hepatitis in Taiwan;
台湾地区慢性乙型肝炎中医辨证论治规律探讨
3.
Methods Serum hyaluronic acid (HA), laminin (LN) and type Ⅲ procollagen (PCⅢ) levels were measured with RIA in 40 patients with chronic B hepatitis treated with matrine and 40 other patients treated without matrine both before and 3, 6 months after treatment as well as in 32 controls.
方法:用放射免疫分析测定了40例慢性乙型肝炎患者治疗前、治疗3、6个月2个治疗阶段血清透明质酸(HA)、层粘蛋白(LN)及Ⅲ型前胶原(PCⅢ)水平,并对测定结果与对照组和正常人组进行统计处理。
6) Chronic Hepatitis B
慢性乙型肝炎(CHB)
1.
To detect the levels of IL-10 and IFN- Y in culture?supernatants of peripheral blood mononuclear cells ( PBMC) in patients with chronic hepatitis B,and to analyse their relation with the grades of intrahepatic inflammation,the amounts of HBV DNA load and the presence of HBeAg in serum.
核苷类抗病毒药物拉米夫定已广泛应用于慢性乙型肝炎（CHB）患者的治疗，其快速降低病毒量、改善肝功能和肝组织病理改变及副作用小等特征已为大量的临床实验证实。
补充资料：慢性活动性乙型肝炎
慢性活动性乙型肝炎
chronic active hepaititis B
病程超过半年，各项症状(消化道症状如厌食、恶心、呕吐、腹胀、腹泻等；神经症状如乏力、萎靡、头晕、失眠等及肝区痛）明显，肝肿大，质地中等以上，可伴有蜘蛛痣、肝掌、毛细血管扩张或肝病面容，进行性脾肿大，肝功能持续异常，或伴有肝外器官损害，或免疫球蛋白、自身抗体持续升高等特征。病理改变以门脉区周围最为明显，门脉区有大量淋巴细胞、浆细胞及巨噬细胞浸润因而扩大。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条